Digital PCR Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Digital PCR Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Digital PCR Market


The global digital PCR market size was valued at USD 584.5 million in 2023 and is projected to grow from USD 706.7 million in 2024 to USD 3678.8 million by 2032, exhibiting a CAGR of 22.9% during the forecast period 2024-2032.

The pandemic bogged down the virtual PCR market due to disruptions in supply chains and reduced calls for non-important scientific devices. However, the need for accurate and sensitive diagnostic gear for COVID-19 checking out subsequently drove a boom in the market. As the pandemic advanced, the digital PCR era played a crucial function in detecting and tracking the virus, leading to elevated adoption and innovation in the field and impeding the rise of digital PCR market growth.

Advancements in virtual PCR (dPCR) generation, together with innovations like droplet and chip-based techniques, are increasing the marketplace increase—the release of the Molecision S6 digital PCR machine through Shenzhen New Industries Biomedical Engineering Co., Ltd. MEDICA, 2022 exemplifies this progress.

As virtual PCR steps out of research labs, consumer-friendliness takes center stage. Manufacturers are growing automatic dPCR structures that streamline workflows, and integration with liquid handling robots accelerates pattern prep, expanding the digital PCR market share globally. Advanced statistics analysis software is also on the upward thrust, presenting automated gear for faster and more reliable consequences, making dPCR an extra reachable and efficient technology for ordinary clinical and diagnostic use.

Comprehensive Analysis of Digital PCR Market

In the digital PCR (dPCR) marketplace, segmentation via type reveals the dominance of the droplet dPCR section, driven by growing product launches for infectious disease analysis and projected significant increase fueled via marketplace emphasis on dPCR development for diagnostics amidst rising disease prevalence. Conversely, the chip-based phase shows slight enlargement, profiting from its sensitivity in detecting pressure specificity. Regarding merchandise, instruments maintain a major marketplace percentage, propelled through the growing adoption of digital technology, at the same time as the reagents & consumables section anticipates the best boom rate, pushed by increased commercialization of digital device kits for analysis, mainly throughout the COVID-19 pandemic with government authorizations similarly boosting market prospects.

The North America region led the digital PCR market by benefitting a size of USD 257.4 million in 2023 due to the vigilant and financially steady population; in addition to the growing adoption of technologically advanced and excessive-fee diagnostics inside the vicinity, the regional marketplace increase is anticipated to be propelled during the forecast duration.

The leading players in the digital PCR (dPCR) market significantly shape its growth trajectory and establish industry standards. Key market participants, including QIAGEN (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), JN Medsys (Singapore), Stilla (France), Sysmex Corporation (Japan), Standard BioTools Inc. (U.S.), and Precigenome LLC. (U.S.), alongside others, contribute to a competitive landscape by driving innovation and market advancement.

In October 2022, Standard BioTools Inc. Added the X9 Real-Time PCR System, a brand-new genomics tool with more desirable potential, handing over superior overall performance.

Segmentation Table

Attribute Details

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth RateCAGR of 22.9% from 2024-2032

Unit Value (USD million)

Segmentation

By Type

Droplet Digital PCR

Chip-based Digital PCR

Others

By Product

Instruments

Reagents & Consumables

By Indication

Infectious Diseases

Oncology

Genetic Disorders

Others

By End-user

Hospitals & Clinics

Pharmaceutical & Biotechnology Industries

Clinical Laboratories

Academic & Research Organizations

By Geography

North America (By Type, Product, By Indication, End-user, and Country)

-U.S.

-Canada

Europe (By Type, Product, By Indication, End-user, and Country/ Sub-region)

-U.K.

-Germany

-France

-Italy

-Spain

-Scandinavia

-Rest of Europe

Asia Pacific (By Type, Product, By Indication, End-user, and Country/Sub-region)

-China

-Japan

-India

-Australia

-Southeast Asia

-Rest of Asia Pacific

Latin America (By Type, Product, By Indication, End-user, and Country/ Sub-region)

-Brazil

-Mexico

-Rest of Latin America

Middle East & Africa (By Type, Product, By Indication, End-user, and Country/ Sub-region)

-GCC

-South Africa

-Rest of Middle East & Africa